首页 / 多肽产品 / 糖尿病类 / 瑞塔鲁肽
筛选
目录肽(按字母分类)
非天然氨基酸及其它砌块合成
瑞塔鲁肽
名称
瑞塔鲁肽
分子结构式
CAS号
2381089-83-2
分子式
C221H342N46O68
分子量
4731.33
作用靶点
GCGR GLP Receptor
序列号
Tyr-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{α-Me-Leu}-Leu-Asp-Lys-{diacid-C20-gamma-Glu-(AEEA)-Lys}-Ala-Gln-{Aib}-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
短序列号
Y-{Aib}-QGTFTSDYSI-{α-Me-Leu}-LDK-{diacid-C20-gamma-Glu-(AEEA)-Lys}AQ-{Aib}-AFIEYLLEGGPSSGAPPPS-NH2
溶解度
50 mg/mL
水中溶解度
20 mg/mL
纯度
95%
引用文献
[1]. Tamer Coskun, et al. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept. Cell Metab. 2022 Sep 6;34(9):1234-1247.e9.
* 本公司网站所有产品用于科学研究,不能用于人体
产品详情
数据下载

Retatrutide is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide binds human GCGR, GIPR, and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively. Retatrutide can be used for the research of obesity.